Cargando…
Protective effect of berberine on acute cardiomyopathy associated with doxorubicin treatment
Doxorubicin (DOX) is a potent and broad-spectrum anthracycline chemotherapeutic agent, but dose-dependent cardiotoxic side effects limit its clinical application. This toxicity is closely associated with the generation of reactive oxygen species (ROS) radical during DOX metabolism. The present study...
Autores principales: | Xiong, Chen, Wu, Yan-Zhao, Zhang, Yu, Wu, Zi-Xiao, Chen, Xue-Yan, Jiang, Ping, Guo, Hui-Cai, Xie, Ke-Rang, Wang, Ke-Xin, Su, Su-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840547/ https://www.ncbi.nlm.nih.gov/pubmed/29552206 http://dx.doi.org/10.3892/ol.2018.8020 |
Ejemplares similares
-
Berberine Ameliorates Doxorubicin-Induced Cardiotoxicity via a SIRT1/p66Shc-Mediated Pathway
por: Wu, Yan-Zhao, et al.
Publicado: (2019) -
Protective effects of berberine on doxorubicin-induced nephrotoxicity in mice
por: Zhao, Xiaoyan, et al.
Publicado: (2012) -
Berberine Protects Glomerular Podocytes via Inhibiting Drp1-Mediated Mitochondrial Fission and Dysfunction
por: Qin, Xin, et al.
Publicado: (2019) -
Berberine protects against diabetic kidney disease via promoting PGC‐1α‐regulated mitochondrial energy homeostasis
por: Qin, Xin, et al.
Publicado: (2020) -
Angiotensin-converting enzyme 2 overexpression protects against doxorubicin-induced cardiomyopathy by multiple mechanisms in rats
por: Ma, Hui, et al.
Publicado: (2017)